Simultaneous High-Frequency Subthalamic and Ultra-Low-Frequency Nigral Deep Brain Stimulation Improved Motor Symptoms and Freezing of Gait in Parkinson’s Disease

View at publisher
Authors: Yan Han, Zhiwei Ren, Wei Mao, Cuiping Xu, Yaqi Wang, Jianyu Li, Shanshan Mei
Cited by: 1
References: 76

Abstract

INTRODUCTION: Freezing of gait (FOG) in advanced Parkinson's disease (PD) remains a therapeutic challenge, with conventional subthalamic nucleus deep brain stimulation (STN-DBS) demonstrating limited efficacy. METHODS: This multicenter, prospective, single-blind study investigated the effects of combined high-frequency STN stimulation and ultra-low-frequency substantia nigra pars reticulata (SNr) stimulation in six PD patients with refractory FOG. Assessments included Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III, New Freezing of Gait Questionnaire (NFOGQ), Gait and Falls Questionnaire (GFQ), and Schwab and England Activities of Daily Living (ADL) scale. RESULTS: Dual-target stimulation significantly outperformed STN-only stimulation in improving appendicular motor symptoms (MDS-UPDRS Part III: p = 0.04 medication-ON, p = 0.009 medication-OFF) and reducing FOG severity (NFOGQ: p = 0.02, GFQ: p = 0.01 vs. STN-DBS). Postural stability remained unchanged, while ADL scores improved clinically (p = 0.04). Volume of tissue activated (VTA) analysis revealed more STN VTA connectivity in cerebrum, in contrast with more SNr VTA connectivity in cerebellum. CONCLUSION: These findings highlight the potential of dual-target free-frequency DBS for multimodal symptom control in PD and hopefully bring new sights in understanding mechanisms of DBS treatments in FOG.

Fields of Study & Subjects

Neurological disorders and treatments Transcranial Magnetic Stimulation Studies Parkinson's Disease Mechanisms and Treatments

Publication details

Journal / source
Stereotactic and Functional Neurosurgery
Publisher
S. Karger AG
Volume
104
Issue
4
Pages
256–267
Publication date
19 January 2026
Language
EN